# Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients

> **NCT00683124** · PHASE3 · UNKNOWN · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 291 (estimated)

## Conditions studied

- Marfan Syndrome

## Interventions

- **DRUG:** Losartan and nebivolol
- **DRUG:** Losartan
- **DRUG:** Nebivolol

## Key facts

- **NCT ID:** NCT00683124
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 291 (ESTIMATED)
- **Last updated:** 2011-07-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683124, "Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00683124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*